SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-052018
Filing Date
2024-06-12
Accepted
2024-06-12 14:30:02
Documents
2
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea020776001-6k_akandacorp.htm 6-K 8424
2 PRESS RELEASE - AKANDA HAS REGAINED COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE R ea020776001ex99-1_akandacorp.htm EX-99.1 5554
  Complete submission text file 0001213900-24-052018.txt   15053
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 241038115
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)